Replies to post #458655 on Anavex Life Sciences Corp (AVXL)

[kund]

Full data from the blarcamesine in Alzheimer’s disease Phase 2b/3 placebo-controlled clinical trial will be published in an upcoming peer-reviewed journal.

This is another forever catalyst list from clown CEO, how can he say this in every PR? even crooks has some dignity.